Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PD-1
Pharma
Merck's Keytruda improves survival in cervical cancer trial
Trail results show that Merck Keytruda plus chemoradiotherapy can improve overall survival in patients with earlier-stage cervical cancer.
Kevin Dunleavy
Mar 15, 2024 11:31am
Checkpoint slapped with CRL for skin cancer hopeful cosibelimab
Dec 19, 2023 10:11am
Keytruda snags FDA nod for NSCLC treatment around surgery
Oct 16, 2023 6:24pm
Merck eyes new bladder cancer space with positive Keytruda trial
Oct 5, 2023 11:16am
Coherus, Junshi eye FDA finish line after plant inspection
Jun 1, 2023 9:40am
After a clinical beating, Merck's Keytruda is on the up-and-up
Mar 1, 2023 10:27am